본문 바로가기
bar_progress

Text Size

Close

A Whopping 600 Times! Better Than Remde...! Five Stars!!

Those who applied for hit the upper limit in just one day! Achieved 31% profit!

Congratulations to everyone who applied for the free trial. ^^


※If you missed the “COVID-19 treatment” opportunity, no worries. We are going out strong once again.

※Finally starting. PARKUS (065690) follow-up stock hits the upper limit on Tuesday. ※


▶▶ Starting with a huge ‘upper limit’ on September 1, COVID-19 treatment candidate Remdesivir is outperformed by 600 times! ‘ㅇㅇㅇㅇㅇ’ related stock! ▶ Apply for free trial ◀


As Nafamostat gains prominence as a COVID-19 treatment candidate, Ono Pharmaceutical in Japan is conducting clinical trials, and efficacy research and clinical experiments are actively underway overseas including the U.S.!!

Amid the global race to develop COVID-19 treatments, domestic clinical patient administration of Nafamostat is underway, with the ‘Gyeongsang National University-NewG Lab’ team taking the lead, drawing attention to the results!!



▶▶ Heading straight to ‘上’ on Tuesday. Moving fast. COVID-19 treatment Remdesivir outperformed by 600 times! Related beneficiary stocks! Don’t miss out [Apply now for ‘COVID-19 treatment Remdesivir outperformed by 600 times’ related stocks]


"I applied and bought small amounts every day for 3 days, and was amazed to see upper limit profits every day. I was really surprised. How is this possible? It’s truly amazing. It’s been about 3 months since I paid the membership fee and received VIP service, and already 30 million KRW has accumulated in my account. Thank you so much again. Ah! I am actively recommending it to my acquaintances as well."

(VIP office worker member Yoo Jin Lee, 41 years old)


Now think of this as your last chance. If you miss this opportunity, you have to give up.

Exactly on “September 1” it will explode! Don’t miss out and regret it, buy even just 1 million KRW!



▶▶ “September 1 upper limit” offered only until today and then closed. [Receive ‘COVID-19 treatment Remdesivir outperformed by 600 times’ related stocks!] ▶ Receive stocks ◀


[AI recent upper limit hits]

*20.08.28 PARKUS (065690) hit upper limit!

*20.08.27 Bodytech Med (206640) hit upper limit!

*20.08.26 Telcon RF Pharmaceutical (200230) hit upper limit!

*20.08.25 Woori Bio (082850) hit upper limit!

*20.08.24 Jinwon Life Science (011000) hit upper limit!

*20.08.21 Exa Inc. (054940) hit upper limit!

*20.08.20 Wooridul Pharmaceutical (004720) 3 consecutive upper limits hit!

*20.08.19 Wooridul Pharmaceutical (004720) 2 consecutive upper limits hit!

*20.08.18 Wooridul Pharmaceutical (004720) hit upper limit!

*20.08.14 KNN (058400) hit upper limit!

*20.08.13 HLB (028300) hit upper limit!

*20.08.12 Ilsin Bio (068330) hit upper limit!

*20.08.11 Korea BioGen (318000) hit upper limit!

*20.08.10 CIS (222080) hit upper limit!

*20.08.07 Seoyeon Top Metal (019770) hit upper limit!

*20.08.06 Hyosung O&B (097870) hit upper limit!

*20.08.05 DA Technology (196490) hit upper limit!

*20.08.04 Kainos Med (284620) hit upper limit!

*20.08.03 Access Bio (950130) hit upper limit!

*20.07.31 BioSmart (038460) hit upper limit!

*20.07.30 Simtek (222800) hit upper limit!

*20.07.29 Bitsro Tech (042370) hit upper limit!


▶▶ Only 30 spots available. “Tuesday upper limit”! ▶ Get it now ◀


※First-come, first-served 30 spots closed! Both early and late rounds are finished. The hero of the final injury time winning goal※


[Today's stocks of interest]

#NewG Lab #Seoul Pharmaceutical #Shinpoong Pharmaceutical #Joah Pharmaceutical #AminoLogics


※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top